help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedley, D.
Right arrow Articles by Hill, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedley, D.
Right arrow Articles by Hill, R.
(American Journal of Pathology. 2004;164:557-565.)
© 2004 American Society for Investigative Pathology

Up-Regulation of the Redox Mediators Thioredoxin and Apurinic/Apyrimidinic Excision (APE)/Ref-1 in Hypoxic Microregions of Invasive Cervical Carcinomas, Mapped Using Multispectral, Wide-Field Fluorescence Image Analysis

David Hedley*{dagger}{ddagger}, Melania Pintilie§, Jennifer Woo*, Trudey Nicklee*, Andrew Morrison*, Diana Birle*{ddagger}, Anthony Fyles¶||, Michael Milosevic¶|| and Richard Hill*{ddagger}

From the Division of Experimental Therapeutics* and the Departments of Medical Oncology and Hematology,{dagger} Biostatistics,§ and Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto; and the Departments of Medical Biophysics{ddagger} and Radiation Oncology,|| University of Toronto, Toronto, Ontario, Canada

Thioredoxin and apurinic/apyrimidinic excision (APE)/ref-1 are important redox mediators in biochemical pathways that promote cell survival under adverse conditions including hypoxia and oxidative stress. For example, elevated levels occur surrounding vascular infarcts and protect from reperfusion injury. Because elevated thioredoxin or APE/ref-1 is also associated with resistance to certain forms of cancer treatment, we examined their tissue distribution in a series of 110 cervical carcinoma biopsies. Analysis was done using a quadruple fluorescence imaging technique, incorporating carbonic anhydrase IX (CAIX) immunofluorescence to outline hypoxic microregions and 4',6-diamidino-2-phenylindole to localize nuclear staining of thioredoxin and APE/ref-1. A scanning autostage was used to image the entire tissue section. Thioredoxin and APE/ref-1 levels were expressed as the average pixel brightness in tumor tissue, subdivided based on CAIX and 4',6-diamidino-2-phenylindole staining. Results showed that the nuclear and cytoplasmic levels of thioredoxin were similar, whereas APE/ref-1 expression was greater in nuclei. Neither of these markers was predictive of outcome in this series of patients treated with radical radiotherapy. Both proteins showed highly significant elevations in CAIX-positive regions compared to CAIX-negative regions, and there was a nonsignificant trend for this effect to be greater in adenocarcinomas compared to squamous cell carcinomas. Levels of APE/ref-1 decreased with increasing tumor grade, but the expression was similar in CAIX-positive regions of poorly differentiated tumors compared to moderately or well-differentiated tumors. Elevated expression of thioredoxin and APE/ref-1 might promote cancer cell survival in hypoxic microenvironments of cervical carcinomas.





This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
S. El-Mouatassim, S. Bilotto, G. L. Russo, E. Tosti, and Y. Menezo
APEX/Ref-1 (apurinic/apyrimidic endonuclease DNA-repair gene) expression in human and ascidian (Ciona intestinalis) gametes and embryos
Mol. Hum. Reprod., August 1, 2007; 13(8): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. C. Birle and D. W. Hedley
Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts.
Mol. Cancer Ther., October 1, 2006; 5(10): 2494 - 2502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.